Carol A. Carter

1.4k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Carol A. Carter is a scholar working on Virology, Molecular Biology and Cell Biology. According to data from OpenAlex, Carol A. Carter has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Virology, 15 papers in Molecular Biology and 14 papers in Cell Biology. Recurrent topics in Carol A. Carter's work include HIV Research and Treatment (24 papers), Cellular transport and secretion (13 papers) and Ubiquitin and proteasome pathways (8 papers). Carol A. Carter is often cited by papers focused on HIV Research and Treatment (24 papers), Cellular transport and secretion (13 papers) and Ubiquitin and proteasome pathways (8 papers). Carol A. Carter collaborates with scholars based in United States and Japan. Carol A. Carter's co-authors include Lorna S. Ehrlich, Jonathan Leis, Fadila Bouamr, Alexandra Kikonyogo, Tracy J. LaGrassa, Lynn VerPlank, Gisselle N. Medina, Susan M. Watanabe, Benjamin Chu and Suzanne Scarlata and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Carol A. Carter

28 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55 ^Gag

2001 501 citations Fadila Bouamr, Jonathan Leis et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Carol A. Carter

Since Specialization

Citations

This map shows the geographic impact of Carol A. Carter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carol A. Carter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carol A. Carter more than expected).

Fields of papers citing papers by Carol A. Carter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carol A. Carter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carol A. Carter. The network helps show where Carol A. Carter may publish in the future.

Co-authorship network of co-authors of Carol A. Carter

This figure shows the co-authorship network connecting the top 25 collaborators of Carol A. Carter. A scholar is included among the top collaborators of Carol A. Carter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carol A. Carter. Carol A. Carter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High Risk, High Reward: By Selecting Tsg101, A Protein That Sorts The Trash, As Our Personal ESCRT, Both HIV And I Were Able To Bud 2025 ·Journal of Molecular Biology ·Carol A. Carter	0
2	Tsg101 UEV Interaction with Nedd4 HECT Relieves E3 Ligase Auto-Inhibition, Promoting HIV-1 Assembly and CA-SP1 Maturation Cleavage 2024 ·Viruses ·Susan M. Watanabe, David A. Nyenhuis, Mahfuz Khan, Lorna S. Ehrlich, Irene Ischenko, Michael D. Powell, Nico Tjandra, Carol A. Carter	3
3	Tsg101 mimicry of canonical E2 enzymes underlies its role in ubiquitin signaling 2024 ·Proceedings of the National Academy of Sciences ·David A. Nyenhuis, Susan M. Watanabe, Nico Tjandra, Carol A. Carter	2
4	HECT domain interaction with ubiquitin binding sites on Tsg101-UEV controls HIV-1 egress, maturation, and infectivity 2023 ·Journal of Biological Chemistry ·David A. Nyenhuis, (unknown), Susan M. Watanabe, Marie‐Paule Strub, Mahfuz Khan, Michael D. Powell, Carol A. Carter, Nico Tjandra	5
5	Tsg101/ESCRT-I recruitment regulated by the dual binding modes of K63-linked diubiquitin 2022 ·Structure ·Madeleine Strickland, Susan M. Watanabe, (unknown), (unknown), Mary R. Starich, David Fushman, Carol A. Carter, Nico Tjandra	12
6	Novel Tsg101 Binding Partners Regulate Viral L Domain Trafficking 2021 ·Viruses ·Madeleine Strickland, David A. Nyenhuis, Susan M. Watanabe, Nico Tjandra, Carol A. Carter	9
7	Tsg101 chaperone function revealed by HIV-1 assembly inhibitors 2017 ·Nature Communications ·Madeleine Strickland, Lorna S. Ehrlich, Susan M. Watanabe, Mahfuz Khan, Marie‐Paule Strub, Chi-Hao Luan, Michael D. Powell, Jonathan Leis, Nico Tjandra, Carol A. Carter	38
8	The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibility 2016 ·Retrovirology ·Susan M. Watanabe, Viviana Simon, Natasha D. Durham, (unknown), (unknown), Kimdar Sherefa Kemal, (unknown), Brian Foley, Hongru Li, Benjamin K. Chen, Barbara Weiser, Harold Burger, Kathryn Anastos, Chaoping Chen, Carol A. Carter	5
9	Tsg101 regulates PI(4,5)P2/Ca2+ signaling for HIV-1 Gag assembly 2014 ·Frontiers in Microbiology ·Lorna S. Ehrlich, Gisselle N. Medina, (unknown), (unknown), Susan M. Watanabe, Justin W. Taraska, Carol A. Carter	8
10	The S40 residue in HIV-1 Gag p6 impacts local and distal budding determinants, revealing additional late domain activities 2013 ·Retrovirology ·Susan M. Watanabe, Min‐Huei Chen, Mahfuz Khan, Lorna S. Ehrlich, Kimdar Sherefa Kemal, Barbara Weiser, (unknown), Chaoping Chen, Michael D. Powell, Kathryn Anastos, Harold Burger, Carol A. Carter	13
11	Sprouty2 Regulates PI(4,5)P2/Ca2+ Signaling and HIV-1 Gag Release 2011 ·Journal of Molecular Biology ·Lorna S. Ehrlich, Gisselle N. Medina, Carol A. Carter	7
12	Phosphoinositides Direct Equine Infectious Anemia Virus Gag Trafficking and Release 2010 ·Traffic ·Fiona Fernandes, Kang Chen, Lorna S. Ehrlich, Jing Jin, (unknown), Gisselle N. Medina, Marc Symons, Ronald C. Montelaro, Julie G. Donaldson, Nico Tjandra, Carol A. Carter	43
13	Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting 2008 ·Virology ·Gisselle N. Medina, Andrew Pincetic, Lorna S. Ehrlich, Yongjun Zhang, Yi Tang, Jonathan Leis, Carol A. Carter	31
14	The Functionally Exchangeable L Domains in RSV and HIV‐1 Gag Direct Particle Release Through Pathways Linked by Tsg101 2005 ·Traffic ·Gisselle N. Medina, Yongjun Zhang, Yi Tang, Eva Gottwein, Marcy L. Vana, Fadila Bouamr, Jonathan Leis, Carol A. Carter	43
15	Structural and Dynamics Studies of the D54A Mutant of Human T Cell Leukemia Virus-1 Capsid Protein 2004 ·Journal of Biological Chemistry ·Fadila Bouamr, Claudia C. Cornilescu, Stephen P. Goff, Nico Tjandra, Carol A. Carter	12
16	Tsg101: HIV-1's ticket to ride 2002 ·Trends in Microbiology ·Carol A. Carter	40
17	HIV-1 Capsid Protein Forms Spherical (Immature-Like) and Tubular (Mature-Like) Particles in Vitro: Structure Switching by pH-induced Conformational Changes 2001 ·Biophysical Journal ·Lorna S. Ehrlich, Tianbo Liu, Suzanne Scarlata, Benjamin Chu, Carol A. Carter	83
18	Effect of pH and nonphysiological salt concentrations on human immunodeficiency virus-1 protease dimerization 1994 ·Biochemistry and Cell Biology ·Suresh C. Tyagi, Sanford R. Simon, Carol A. Carter	6
19	Continuous assay of the hydrolytic activity of human immunodeficiency virus-1 protease 1992 ·Analytical Biochemistry ·Suresh C. Tyagi, Carol A. Carter	6
20	Expression in Escherichia coli and Purification of Human Immunodeficiency Virus Type 1 Capsid Protein (p24) 1990 ·AIDS Research and Human Retroviruses ·Lorna S. Ehrlich, (unknown), Eckard Wimmer, Carol A. Carter	43

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact